{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-004654","form_type":"8-K","ticker":"PROF","cik":"0001628808","company_name":"Profound Medical Corp.","filed_at":"2026-07-15T12:00:32+00:00","discovered_at":"2026-07-15T12:05:00.389740+00:00","generated_at":"2026-07-15T12:05:05.053147+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Profound Medical's TULSA Procedure to be featured at SRS Annual Meeting July 23-26","bullets":["TULSA Procedure highlighted in multiple presentations at SRS2026 in Fort Lauderdale, FL.","CAPTAIN randomized trial comparing TULSA vs. radical prostatectomy: primary safety outcomes presented July 24.","Real-world outcomes from multicenter post-market registry presented by UT Southwestern.","Profound selected as one of eight companies for Society of Incisionless Surgery plenary session.","Management to participate in investor session on July 22 moderated by Stifel and Wells Fargo analysts."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-004654","json":"https://secwatch.observer/filing/0001171843-26-004654.json","markdown":"https://secwatch.observer/filing/0001171843-26-004654.md","text":"https://secwatch.observer/filing/0001171843-26-004654.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326004654/0001171843-26-004654-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628808/000117184326004654/f8k_071526.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-15T12:05:05.053147+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}